Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)
NCT01201811
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Myelodysplastic Syndromes
Interventions
DRUG:
Azacitidine
Sponsor
Celgene